【レポートの概要(一部)】
1. Executive Summary
1.1 Top Stem Cell Technology Companies: Overview of Findings
1.2 Report Contents
1.3 Study Methods – Research and Analysis
1.4 Scope and Format of Report
2. Leading US Stem Cell Technology Companies, 2014
2.1 Aastrom Biosciences
2.1.1 Stem Cell Technology Platform
2.1.2 Aastrom: Stem Cell Pipeline, 2014
2.1.2.1 Ixmyelocel-T: Patient-Specific Therapy Reduces Risk of Rejection
2.1.2.2 Orphan Designation to Accelerate Product Development
2.1.3 Sales and Recent Performance, 2012
2.1.4 Aastrom: Stem Cell SWOT Analysis, 2014-2024
2.1.5 Aastrom: Stem Cell Revenue Forecast, 2014-2024
2.2 Advanced Cell Technology (ACT)
2.2.1 Stem Cell Technology Platform
2.2.2 ACT: Stem Cell R&D Pipeline, 2014
2.2.2.1 Human Embryonic Stem Cells: Aiding Tissue Repair
2.2.3 Sales and Recent Performance, 2012
2.2.4 ACT: Stem Cell SWOT Analysis, 2014-2024
2.2.5 ACT: Stem Cell Revenue Forecast, 2014-2024
2.3 Bioheart
2.3.1 Bioheart: Stem Cell Pipeline, 2014
2.3.2 Sales and Recent Performance, 2012
2.3.3 Bioheart: Stem Cell SWOT Analysis, 2014-2024
2.3.4 Bioheart: Stem Cell Revenue Forecast, 2014-2024
2.3.4.1 Increased Activity Abroad Will Help Bioheart Attract Investment
2.4 BrainStorm Cell Therapeutics
2.4.1 Brainstorm Cell Therapeutics: Stem Cell Pipeline, 2014
2.4.2 Brainstorm Cell Therapeutics: Stem Cell SWOT Analysis, 2014-2024
2.4.3 Brainstorm Cell Therapeutics: Stem Cell Revenue Forecast, 2014-2024
2.4.3.1 Government Grant Will Provide Much Needed Investment
2.5 California Stem Cell Inc.
2.5.1 California Stem Cell: Stem Cell Pipeline, 2014
2.5.2 California Stem Cell: Stem Cells SWOT Analysis, 2014-2024
2.6 International Stem Cell Corporation (ISCO)
2.6.1 ISCO: Stem Cell Pipeline, 2014
2.6.2 Sales and Recent Performance, 2012
2.6.3 ISCO: Stem Cells SWOT Analysis, 2014-2024
2.6.4 Cosmetic Subsidiary Expands Into Asian Market
2.7 NeoStem
2.7.1 NeoStem: Stem Cell Pipeline, 2014
2.7.1.1 AMR-001: Highly Efficacious Therapy for AMI
2.7.1.2 T-Cell Therapy: Using Autologous Immune Cells as Therapy
2.7.1.3 VSEL Technology: Promoting Cell Migration to Site of Damage
2.7.2 Sales and Recent Performance, 2012
2.7.3 NeoStem: Stem Cell SWOT Analysis, 2014-2024
2.7.4 NeoStem: Stem Cell Revenue Forecast, 2014-2024
2.8 Neuralstem
2.8.1 Stem Cell Technology Platform
2.8.2 Neuralstem: Stem Cell Pipeline, 2014
2.8.2.1 NSI-566: Potential Therapy in Multiple Neurological Disorders
2.8.2.2 NSI-189: Deriving Cells from the Hippocampal Region
2.8.3 Sales and Recent Performance, 2012
2.8.4 Neuralstem: Stem Cell SWOT Analysis, 2014-2024
2.8.5 Neuralstem: Stem Cell Revenue Forecast, 2014-2024
2.9 Medistem
2.9.1 Medistem: Stem Cell Pipeline, 2014
2.9.2 Medistem: Stem Cell SWOT Analysis, 2014-2024
2.9.3 Medistem: Stem Cell Revenue Forecast, 2014-2024
2.9.3.1 Expansion of Clinical Indications Through Acquisition
2.10 Osiris Therapeutics
2.10.1 Osiris Therapeutics: Stem Cell Products
2.10.2 Osiris Therapeutics: Stem Cell Pipeline, 2014
2.10.3 Sales and Recent Performance, 2012
2.10.4 Osiris Therapeutics: Stem Cell SWOT Analysis, 2014-2024
2.10.5 Osiris Therapeutics: Stem Cell Revenue Forecast, 2014-2024
2.11 Other US Companies Operating in the Stem Cells Technology Industry, 2014
3. Top European and Israeli Stem Cell Technology Companies, 2014
3.1 Apceth
3.1.1 Apceth: Stem Cell Pipeline, 2014
3.1.1.1 Alecmestencel-T: Options for Autologous and Allogeneic Therapy
3.1.1.2 Agenmestencel-T: Genetically-modified Therapy for Cancer
3.1.2 Apceth: Stem Cell SWOT Analysis, 2014-2024
3.1.3 Apceth: Stem Cell Revenue Forecast, 2014-2024
3.2 Cardio3 BioSciences
3.2.1 Cardio3 BioSciences: Stem Cell Pipeline, 2014
3.2.1.1 C-Cure®: Creating New Muscle Cells
3.2.2 Cardio3 BioSciences: Stem Cell SWOT Analysis, 2014-2024
3.2.3 Cardio3 BioSciences: Stem Cell Revenue Forecast, 2014-2024
3.3 Cell Cure Neurosciences
3.3.1 Cell Cure Neurosciences: Stem Cell Pipeline, 2014
3.3.2 Cell Cure Neurosciences: Stem Cell SWOT Analysis, 2014-2024
3.4 TiGenix
3.4.1 Stem Cell Technology Platform
3.4.2 TiGenix: Stem Cell Products
3.4.2.1 ChondroCelect: One of Few Marketed Stem Cell Products
3.4.3 TiGenix: Stem Cell Pipeline, 2014
3.4.3.1 Cx601: Promoting Natural Close of Fissure
3.4.3.2 Cx611: Landmark Results of a Cell Therapy in Rheumatoid Arthritis
3.4.3.3 Cx621: Novel, Painless Route of Administration?
3.4.4 Sales and Recent Performance, 2012
3.4.5 TiGenix: Stem Cell SWOT Analysis, 2014-2024
3.4.6 TiGenix: Stem Cell Revenue Forecast, 2014-2024
3.5 Gamida Cell
3.5.1 Stem Cell Technology Platform
3.5.1.1 Copper Chelator-based Technology
3.5.1.2 Nicotinamide (NAM) Platform
3.5.2 Gamida Cell: Stem Cell Pipeline, 2014
3.5.2.1 StemEx: Huge Market Potential in Patient Numbers
3.5.2.2 NiCord: Transplanting Two Units of Umbilical Cord Blood
3.5.3 Gamida Cell: Stem Cell SWOT Analysis, 2014-2024
3.5.4 Gamida Cell: Stem Cell Revenue Forecast, 2014-2024
3.6 Pluristem Therapeutics
3.6.1 Stem Cell Technology Platform:
3.6.2 Pluristem Therapeutics: Stem Cell Pipeline, 2014
3.6.2.1 PLX-PAD: Clinical Hold Notification May Delay Approval
3.6.2.2 PLX-RAD: Accelerating Cell Engraftment in Bone Marrow Transplantation
3.6.3 US and Korea Licence Partnerships to Drive Revenue
3.6.4 Sales and Recent Performance, 2013
3.6.5 Pluristem Therapeutics: Stem Cell SWOT Analysis, 2014-2024
3.6.6 Pluristem Therapeutics: Stem Cell Revenue Forecast, 2014-2024
3.7 ReNeuron
3.7.1 ReNeuron: Stem Cell Technology Platform
3.7.2 ReNeuron: Stem Cell Pipeline, 2014
3.7.2.1 ReN001: Groundbreaking Therapy in Development
3.7.2.2 ReN009: Avoiding Possible Limb Amputation
3.7.2.3 ReN003: Grant and Partnership with Leading US University Will Drive Development
3.7.3 Sales and Recent Performance, 2013
3.7.4 ReNeuron: Stem Cell SWOT Analysis, 2014-2024
3.7.5 ReNeuron: Stem Cell Revenue Forecast, 2014-2024
3.8 Other European and Israeli Companies Operating in the Stem Cells Technology Industry, 2014
4. Top Asia-Pacific Stem Cell Technology Companies, 2014
4.1 Anterogen
4.1.1 Anterogen: Stem Cell Products
4.1.1.1 Cupistem®: World’s First MSC Product From Adipose Tissue
4.1.1.2 Queencell®:
4.1.2 Anterogen: Stem Cell Pipeline, 2014
4.1.3 Anterogen: Stem Cell SWOT Analysis, 2014-2024
4.2 MEDIPOST
4.2.1 Stem Cell Technology Platform
4.2.2 MEDIPOST: Stem Cell Pipeline, 2014
4.2.2.1 Cartistem: A Top 25 Science Technology
4.2.2.2 Neurostem: Restorative Therapy for Neurological Disease
4.2.2.3 Pneumostem: Treatment for Paediatric Population
4.2.2.4 Promostem: Encouraging Engraftment of Cells Following Transplantation
4.2.3 Sales and Recent Performance, 2014
4.2.4 MEDIPOST: Stem Cell SWOT Analysis, 2014-2024
4.2.5 MEDIPOST: Stem Cell Revenue Forecast, 2014-2024
4.2.5.1 Collaboration with an Indian Company Expands Reach in Asia
4.3 Mesoblast
4.3.1 Stem Cell Technology Platform
4.3.2 Mesoblast: Stem Cell Pipeline, 2014
4.3.2.1 Immunology and Inflammatory Diseases
4.3.2.2 Spinal Disease
4.3.2.3 Cardiac and Vascular Disease
4.3.2.4 Oncology
4.3.2.5 Other Indications
4.3.3 Sales and Recent Performance, 2012
4.3.4 Mesoblast: Stem Cell SWOT Analysis, 2014-2024
4.3.5 Mesoblast: Stem Cell Revenue Forecast, 2014-2024
4.4 Pharmicell
4.4.1 Pharmicell: Stem Cell Products
4.4.1.1 Hearticellgram-AMI: World First Cell Therapy for Acute Myocardial Infarction
4.4.2 Pharmicell: Stem Cell Pipeline, 2014
4.4.3 Sales and Recent Performance, 2012
4.4.4 Pharmicell: Stem Cell SWOT Analysis, 2014-2024
4.4.5 Pharmicell: Stem Cell Revenue Forecast, 2014-2024
4.5 Stempeutics Research
4.5.1 Stem Cell Technology Platform
4.5.2 Stempeutics Research: Stem Cell Pipeline, 2014
4.5.2.1 Stempeucel®: Launch in Fast-Growing Asian Markets
4.5.2.2 Stempeucare™: Cosmetic Growth Factor Treatment
4.5.3 Stempeutics Research: Stem Cell SWOT Analysis, 2014-2024
4.5.4 Stempeutics Research: Stem Cell Revenue Forecast, 2014-2024
4.5.4.1 Cipla Alliance to Drive Revenue as Wider Population Targeted
5. The World Stem Cell Technology Market, 2014-2024
5.1 The World Stem Cell Technology Market, 2012
5.2 The World Stem Cell Technology Market: Revenue Forecast to 2024
5.2.1 What Will Drive The World Stem Cell Technology Market Between 2014 and 2024?
5.2.2 What Factors are Likely to Restrain the World Stem Cell Technology Market Between 2014 and 2024?
5.3 The Stem Cell Technology Market: Revenue Forecast by Therapeutic Application, 2014-2024
5.3.1 How Will Market Shares of Leading Stem Cell Therapeutic Applications Change from 2014-2024?
6. Stem Cell Technologies: Industry Trends, 2014-2024
6.1 Strengths and Weaknesses of The Stem Cell Technologies Market
6.2 Strengths
6.2.1 Stem Cells Are Finally Proving Their Worth
6.3 Weaknesses
6.3.1 Many Difficulties Still to Overcome
6.4 Opportunities and Threats in the Stem Cell Technologies Market
6.4.1 Stem Cells Have Unprecedented Clinical Potential
6.4.2 Regulatory and Commercial Instability Threatens the Field
6.5 STEP Analysis of the Stem Cell Technologies Market, 2014-2024
6.5.1 Social Concerns: A Controversial Technology
6.5.2 Technological Developments: Stem Cell Science Still on the March
6.5.3 Economic Factors: Funding Gaps a Concern
6.5.4 Political Issues: State Attitudes Vital to Research Environment
7. Opinions from Research Interviews
7.1 Dr Robin Smith: Chairman and CEO, NeoStem
7.1.1 The Potential of Stem Cell Therapy
7.1.2 Competition in the Stem Cell Arena
7.1.3 NeoStem’s Products and Technology
7.1.4 Concerns over Stem Cell Therapy
7.1.5 Future Directions for NeoStem and Stem Cell Therapy
7.2 Dr Yael Margolin, President and CEO, Gamida Cell
7.2.1 Stem Cell Therapy and Their Therapeutic Promise
7.2.2 Gamida Cell’s NiCord Product and Umbilical Cord Blood
7.2.3 Partnership with a Leading Pharmaceutical Company
7.2.4 Barriers to Stem Cell Therapy Uptake
8. Conclusions
8.1 The US Leads the Field for Stem Cell Research
8.2 Market Remains Under-Capitalised, in Need of Financing
8.3 Many Barriers Still to Overcome for Companies
8.4 New Entrants to the Market Will Increase Competition
【レポート販売概要】
■ タイトル:主要な幹細胞(ステムセル)技術企業分析(2014-2024)■ 英文:Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024
■ 発行日:2014年3月
■ 調査会社:visiongain
■ 商品コード:Visiongain-4052643
■ 調査対象地域:グローバル
- Free T3の市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Free T3 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC …
- Saudi ArabiaのAmmonium Chloride市場:貿易(輸入、輸出)動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for ammonium chloride. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on ammonium chloride export/import operations in Saudi Arabia. The 2002-2012 period is …
- 世界のパブリッククラウド市場動向(2012-2016)TechNavio's analysts forecast the Global Public Cloud market to grow at a CAGR of 29.96 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce overall expenditure on IT infrastructure. The Global Public Cloud market has also been witnessing the increasing availability of high bandwidth services. However, the privacy of data in the cloud i …
- 脊椎用インプラントの世界市場:融合インプラント、非融合インプラントAbout the Spinal Implants Market Spinal implants help correct the deformities of the spine, facilitate bone fusion, and strengthen and stabilize the spine. Conditions such as chronic pain due to degenerative disc diseases (DDDs) and fractures in the spine caused by trauma or osteoporosis can be treated through surgeries that involve the implantation of spinal implants for bone fusion. Spondylolist …
- 医療機器リーダーシリーズ:コンパニオン診断薬(CDx)開発、製造および販売のトップ企業2016Companion Diagnostics – Discover Leading Companies’ Activities and Outlooks How are companies in the companion diagnostics (CDx) industry performing? Visiongain’s new report gives you data, analysis and discussions for producers of those medical devices. Our study lets you assess top companies in that industry and market, showing you their activities and outlooks. There you see financial results, …
- フィルターの世界市場分析:製品別(流体、ICエンジン、空気)、用途別(自動車、消費者用、公益事業、産業用・製造業)、セグメント予測、-2020The Global Filters Market is expected to reach USD 88.19 billion by 2020, according to a new study by Grand View Research, Inc. Growing consumer awareness on account of rising environmental concerns is expected to remain a key driving factor for the global market. In addition, favorable regulatory scenario coupled with increasing demand for automobile and consumer goods is also expected to have a …
- フレキシブル電池の世界市場予測(~2022):種類別(薄膜(リチウムイオン、リチウムポリマー)、プリンテッド、曲面)、充電性別、用途別The flexible battery market is expected to be worth USD 958.4 Million by 2022, at a CAGR of 46.6% between 2016 and 2022. The growth of this market is propelled by the increasing miniaturization of electronics devices, need for thin and flexible batteries in consumer electronics, and the growing demand for wearable devices. The market has been segmented on the basis of type, chargeability, applicat …
- 射撃検知システムの世界市場予測(~2022年)The gunshot detection system market is projected to grow from USD 726.3 Million in 2016 to USD 3,099.8 Million by 2022, at a CAGR of 27.36% during the forecast period. Factors such as lack of stringent gun-ownership laws and easy availability of guns have resulted in an increase in gun deaths in the U.S. The use of gunshot detection systems in the military has increased due to the rise of terroris …
- 種子の世界市場予測(~2022):作物別、種類別(GM、従来型)、 種子形質別、種子処理別、地域別The global seed market has grown exponentially in the last few years. The market size is projected to reach USD 113.28 Billion by 2022, at a CAGR of around 9.9% from 2017. Factors such as increasing acceptance and area under cultivation of GM crops, improvement in Seed Replacement Rate (SRR), and change in science and technology advancements are some of the major drivers of this market. India, Jap …
- 食品用ガスの世界市場:タイプ別(二酸化炭素、窒素、その他)、用途別(凍結&冷却、包装&炭酸化)、エンドユーザー別(飲料、肉&シーフード、および包装製品)Food grade gases are additives, which play a significant role in the preservation and food packaging processes. These gases are majorly used to grind, freeze, and package a variety of products, which include dairy & bakery items, fish & seafood, beverages, poultry products, vegetables & fruits, and prepared meals. In addition, for maintaining the quality of food, the use of food grade gases has in …
- Crescent Point Energy Corp.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Crescent Point Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Crescent Point Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 航空交通管制(ATC)装置の世界市場:通信装置、ナビゲーション装置、監視装置The Air Traffic Control (ATC) equipment market forecast report offers a complete analysis of the market across the forecast period of six years from 2014-2020. It provides an analysis of factors driving the market, restraining the market growth, opportunities, and challenges faced by the industry. The report also provides the market share by product types namely, communication equipment, navigatio …
- Polyoxin Bの世界市場POLYOXIN B (CAS 19396-06-6) Market Research Report 2012 presents comprehensive data on polyoxin b markets globally and regionally (Europe, Asia, North America etc.) The report includes polyoxin b description, covers its application areas and related patterns. It overviews polyoxin b market, names polyoxin b producers and indicates its suppliers. Besides, the report provides polyoxin b prices in re …
- 自動車リコンフィグラブル・インストルメント・クラスター(ダッシュボード)の世界市場2016-2020About Automotive Reconfigurable Instrument Cluster The interest of original equipment manufacturers (OEMs) in modifying the instrument cluster to enhance user experience, offer more useful information, and at the same time improve the aesthetics of the vehicle have collectively lead to several innovative versions of the instrument cluster. Electronic instrument clusters have been in the market as …
- 水痘生ワクチンの世界市場:製品別(一価水痘生ワクチン、水痘生ワクチンの組み合わせ)、用途別(帯状疱疹予防接種、MMRV予防接種)、プロバイダー別(公共プロバイダー、民間プロバイダー)The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026. Varicella live vaccines contain an attenuated form of the varicella zoster virus. These vaccines help build immunity against varicella zoster virus as the infection can cause serious diseases such as chicken pox and herpes zos …